Election countdown: Voting in Assembly District 32 special election in Kern County
Here is a list of poll sites for California’s Assembly District 32 Special Primary Election on February 25:Polls are open on ...
stocknews12h
Is Harmony Biosciences Holdings Inc. (HRMY) a Biotech Stock to Consider?
Harmony Biosciences’ (HRMY) recently released growth plans and pipeline advancements have showcased the company’s dedication ...
Le Lézard13h
The Gross Law Firm Notifies Shareholders of Pacira BioSciences, Inc.(PCRX) of a Class Action Lawsuit and an Upcoming Deadline
The Gross Law Firm issues the following notice to shareholders of Pacira BioSciences, Inc. . Shareholders who purchased shares ...
Phoenix Rising’s new head coach Pa-Modou Kah says 'familial club' coming together
Phoenix Rising FC’s 2025 preseason has kicked off, marking the debut of new head coach, Pa-Modou Kah, who already likes what ...
Neurocrine Biosciences Q4 Earnings Preview: What To Expect After The New Drug Approval
Neurocrine's pipeline includes 12 clinical programs, with two Phase 3 trials due to report in 2025. See why I rate NBIX stock ...
Targeted Oncology8d
FDA Grants Orphan Drug Designation to MB-105 for R/R T-Cell Lymphoma
MB-105, a first-in-class CD5-targeted CAR T-cell therapy, received FDA orphan drug designation for relapsed/refractory T-cell ...
March Biosciences Receives FDA Orphan Drug Designation for MB-105, a First-in-Class CD5 CAR-T Cell Therapy, for T-Cell Lymphoma
Company prepares to advance to Phase 2 clinical trial in early 2025HOUSTON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- March Biosciences (March Bio), an ...
Fintel on MSN14d
Piper Sandler Initiates Coverage of Bright Minds Biosciences (DRUG) with Overweight Recommendation
Fintel reports that on January 23, 2025, Piper Sandler initiated coverage of Bright Minds Biosciences (NasdaqCM:DRUG) with a ...
The Bakersfield Californian14d
PACIRA BIOSCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF ...
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until March 14, 2025 to file lead plaintiff applications in a ...